Osteoarthritis: biological markers for the future?
- 1 December 2002
- journal article
- editorial
- Published by Elsevier in Joint Bone Spine
- Vol. 69 (6) , 525-530
- https://doi.org/10.1016/s1297-319x(02)00446-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritisOsteoarthritis and Cartilage, 2001
- Collagen type II C-telopeptide fragments as an index of cartilage degradationBone, 2001
- Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damageAnnals of the Rheumatic Diseases, 2001
- The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget’s disease of boneBone, 2001
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialThe Lancet, 2001
- Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblastsJournal of Orthopaedic Research, 2000
- Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston county osteoarthritis projectArthritis & Rheumatism, 1999
- Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritisOsteoarthritis and Cartilage, 1998
- Monitoring collagen degradation in patients with arthritis. The search for suitable surrogatesArthritis & Rheumatism, 1996
- Bone Sialoprotein and Osteopontin Distribution at the Osteocartilaginous InterfaceClinical Orthopaedics and Related Research, 1996